Clinical Trial Update: ATG-GCSF in New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ATG-GCSF in new-onset type 1 diabetes completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• ATG-GCSF

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2020-03-02